The leadership team at Quip Laboratories has completed the acquisition of Halosil International, and has established a new company, Halosil International NXT, for ongoing operations.
The acquisition strengthens Quip Laboratories’ commitment to delivering innovative disinfection solutions and expands its capabilities within the industry.
As always, our focus remains on advancing the field of disinfection and ensuring safer environments for organisations worldwide
- Nick Hidell, VP of Halosil International NXT
Halosil International NXT, as part of the Quip Laboratories family of companies, will continue to provide advanced disinfection solutions while maintaining its own distinct identity. As part of the Quip Laboratories family of companies, Halosil International NXT will benefit from expanded capabilities and offerings, while retaining its own distinct identity.
Quip Labs
Founded in 1985, Quip Laboratories has a proven track record in providing biosafety and facility hygiene technologies, including extensive support and marketing of the Halo Disinfection System.
By aligning with Quip Laboratories, Halosil International NXT aims to amplify the reach and impact of its groundbreaking whole room disinfection system, featuring the HaloFogger. This technology has revolutionised industries such as healthcare, hospitality, and food services by delivering exceptional disinfection results.
Nick Hidell, VP of Halosil International NXT, shared his enthusiasm, said: “We are excited about the acquisition of Halosil International and the launch of Halosil International NXT. This strategic move aligns with Quip Laboratories’ commitment to delivering innovative solutions in biosafety and facility hygiene technologies, and we aim to leverage our expanded capabilities and offerings to provide an enhanced customer experience for both Halosil and Quip Labs customers. As always, our focus remains on advancing the field of disinfection and ensuring safer environments for organisations worldwide.”
